Journal: bioRxiv
Article Title: A neuropsychiatric disease-associated mutation in LRRC8B disrupts cellular Ca²⁺ signaling, mitochondrial function, and bioenergetics
doi: 10.64898/2026.04.16.718892
Figure Lengend Snippet: (A) Confocal images of HEK293T cells expressing GFP-LRRC8B (WT) or Y380S Mutant, co-stained with ER-Tracker, Mito-Tracker, and Hoechst. Merged images show ER and mitochondrial localization. Scale bar: 10 µm. (B) Whole-cell patch clamp analysis of current density–voltage relationships under isotonic and hypotonic conditions. No significant differences at +100 mV (mean ± SEM, N = 4; one-way ANOVA, ns). (C) Cell viability (MTT) in GFP(Ctrl), LRRC8B WT, LRRC8BY380S (Mut), siControl (Scr), and siLRRC8B (KD) cells (mean ± SEM, N = 3; one-way ANOVA, ****p < 0.0001). (D) LRRC8B knockdown validated by Western blot and densitometry normalized to actin (mean ± SEM, N = 3; unpaired t-test, **p < 0.01).
Article Snippet: The plasmid encoding GFP-tagged human LRRC8B (HG24935-ACG; Sino Biological Inc, USA).
Techniques: Expressing, Mutagenesis, Staining, Patch Clamp, Knockdown, Western Blot